Cargando…
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
It is estimated that the prevalence rate of Alzheimer’s disease (AD) will double by the year 2040. Although currently available treatments help with symptom management, they do not prevent, delay the progression of, or cure the disease. Interestingly, a shared characteristic of AD and other neurodeg...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868221/ https://www.ncbi.nlm.nih.gov/pubmed/35204096 http://dx.doi.org/10.3390/antiox11020213 |
_version_ | 1784656214649470976 |
---|---|
author | Collins, Andrila E. Saleh, Tarek M. Kalisch, Bettina E. |
author_facet | Collins, Andrila E. Saleh, Tarek M. Kalisch, Bettina E. |
author_sort | Collins, Andrila E. |
collection | PubMed |
description | It is estimated that the prevalence rate of Alzheimer’s disease (AD) will double by the year 2040. Although currently available treatments help with symptom management, they do not prevent, delay the progression of, or cure the disease. Interestingly, a shared characteristic of AD and other neurodegenerative diseases and disorders is oxidative stress. Despite profound evidence supporting the role of oxidative stress in the pathogenesis and progression of AD, none of the currently available treatment options address oxidative stress. Recently, attention has been placed on the use of antioxidants to mitigate the effects of oxidative stress in the central nervous system. In preclinical studies utilizing cellular and animal models, natural antioxidants showed therapeutic promise when administered alone or in combination with other compounds. More recently, the concept of combination antioxidant therapy has been explored as a novel approach to preventing and treating neurodegenerative conditions that present with oxidative stress as a contributing factor. In this review, the relationship between oxidative stress and AD pathology and the neuroprotective role of natural antioxidants from natural sources are discussed. Additionally, the therapeutic potential of natural antioxidants as preventatives and/or treatment for AD is examined, with special attention paid to natural antioxidant combinations and conjugates that are currently being investigated in human clinical trials. |
format | Online Article Text |
id | pubmed-8868221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88682212022-02-25 Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease Collins, Andrila E. Saleh, Tarek M. Kalisch, Bettina E. Antioxidants (Basel) Review It is estimated that the prevalence rate of Alzheimer’s disease (AD) will double by the year 2040. Although currently available treatments help with symptom management, they do not prevent, delay the progression of, or cure the disease. Interestingly, a shared characteristic of AD and other neurodegenerative diseases and disorders is oxidative stress. Despite profound evidence supporting the role of oxidative stress in the pathogenesis and progression of AD, none of the currently available treatment options address oxidative stress. Recently, attention has been placed on the use of antioxidants to mitigate the effects of oxidative stress in the central nervous system. In preclinical studies utilizing cellular and animal models, natural antioxidants showed therapeutic promise when administered alone or in combination with other compounds. More recently, the concept of combination antioxidant therapy has been explored as a novel approach to preventing and treating neurodegenerative conditions that present with oxidative stress as a contributing factor. In this review, the relationship between oxidative stress and AD pathology and the neuroprotective role of natural antioxidants from natural sources are discussed. Additionally, the therapeutic potential of natural antioxidants as preventatives and/or treatment for AD is examined, with special attention paid to natural antioxidant combinations and conjugates that are currently being investigated in human clinical trials. MDPI 2022-01-23 /pmc/articles/PMC8868221/ /pubmed/35204096 http://dx.doi.org/10.3390/antiox11020213 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Collins, Andrila E. Saleh, Tarek M. Kalisch, Bettina E. Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease |
title | Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease |
title_full | Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease |
title_fullStr | Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease |
title_full_unstemmed | Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease |
title_short | Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease |
title_sort | naturally occurring antioxidant therapy in alzheimer’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868221/ https://www.ncbi.nlm.nih.gov/pubmed/35204096 http://dx.doi.org/10.3390/antiox11020213 |
work_keys_str_mv | AT collinsandrilae naturallyoccurringantioxidanttherapyinalzheimersdisease AT salehtarekm naturallyoccurringantioxidanttherapyinalzheimersdisease AT kalischbettinae naturallyoccurringantioxidanttherapyinalzheimersdisease |